申请人:CRYSTAL BIOPHARMACEUTICALS LLC
公开号:WO2013049279A2
公开(公告)日:2013-04-04
The disclosure includes compounds of Formula (1): wherein X1, X2, Q, Z, R1, and R2 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.